Public offering of Nightingale has been oversubscribed and therefore the subscription period has been discontinued
Company Release16 March 2021 at 6:00 p.m. (Finnish time) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.The initial public offering of Nightingale Health Plc (“Nightingale” or the “Company”) to private individuals and entities in Finland, Sweden and Denmark (the “Public Offering”) has been oversubscribed, and therefore the Company’s Board of Directors has decided to discontinue